Document is current
Any future updates will be listed below
-
Authors
Cohen, Jacqueline M. https://orcid.org/0000-0002-7300-0488
Srinivas, Chaitra https://orcid.org/0000-0002-5928-2108
Furu, Kari https://orcid.org/0000-0003-2245-0179
Cesta, Carolyn E. https://orcid.org/0000-0001-5759-9366
Reutfors, Johan https://orcid.org/0000-0003-1372-4262
Karlstad, Øystein https://orcid.org/0000-0003-1204-787X
-
Funding
Funding for this research was provided by:
ADHD Research Network of the Norwegian Centre of Expertise for Neurodevelopmental Disorders and Hypersomnias (#51379, #51379, #51379, #51379)
Norges Forskningsråd (301977, 301977, 301977, 273366, 273366, 301977)
Norwegian Institute of Public Health
- License Information
-
More Information
Article History
Received: 23 August 2022
Accepted: 16 November 2022
First Online: 29 November 2022
Declarations
:
: This study was approved by the Regional Committee for Medical Research Ethics (REK) South-East Norway (2017/2546/REK sør-øst A) and the Swedish Ethical Review Authority (dnr 2015/1826–31/2, 2017/2238–32, 2018/1790–32, 2018/2211–32, 2022/04004–02).
: Carolyn Cesta and Johan Reutfors are employees of the Centre for Pharmacoepidemiology which receives grants from several entities (pharmaceutical companies, regulatory authorities, contract research organizations) for the performance of drug safety and drug utilization studies, unrelated to this work.
